Owners who want to sell a manufacturing company to private equity hear two prices for one set of books. Sponsors answering “sell manufacturing company” sort the plant before they price it. A sponsor already in the industry calls the plant an add-on and talks about six times earnings. A fund that does not yet own a plant in the niche calls the same company a platform and talks about nine. The P&L did not change between the meetings. The role the plant plays in their fund did.
The short answer: the choice is PE platform vs add-on on a manufacturing business for sale. A platform is the company the fund will build on. An add-on is a plant they tuck into a company they already own. Sponsors underwrite four things in a manufacturing business for sale before they pick which label you get: backlog quality, customer concentration, equipment age, and whether a supervisor bench can run a shift without you. Those four decide the multiple more than the state on the building. A worked illustration — not a quote — is the same adjusted EBITDA at 6x as an add-on and 9x as a platform. If the founder is still the estimator, the setup person, and the customer, neither figure is on the table.
This article is not a valuation, a financing commitment, or legal advice. Multiples move with the file, the debt market, and what the buyer already owns. Confirm structure and tax with your counsel and CPA before you treat any range as a price.
How a sponsor differs from a strategic buyer is in selling to private equity vs. a strategic buyer. What follows is the plant version: what they read on the floor, why the same earnings clear two multiples, where out-of-state funds actually shop, and the twelve-month list that changes which of those buyers will bid.
What Private Equity Underwrites in a Plant
A sponsor does not buy a machine list. They buy earnings they believe will still be there when a professional owner, or a platform company they already own, is in charge. Four items show up in every serious manufacturing model.
Backlog quality
A number on a spreadsheet is not a backlog. Sponsors split firm releases from blanket orders, and blankets from a salesperson’s pipeline. They want price, margin after scrap and rework, cancellation terms, and who owns the tooling. A blanket purchase order that the customer can kill on thirty days is a relationship. It is not twelve months of revenue. A release schedule with a margin you can tie to the job cost is a backlog. Quotes that only you can explain do not survive a quality of earnings review. If the last two years were one program launch, isolate that year. Do not annualize it.
Customer concentration
One OEM, one retailer, or one program at a quarter of shipments changes the deal. Sponsors haircut it, structure it, or pass. Written term and a real switching cost help. Silence does not. They will ask for the top ten accounts, the margin on each, and what happens if the largest one dual-sources you. That is the same problem we describe in customer concentration and key-person risk, with a plant attached: the “person” may be a quality engineer the customer will only talk to, or a founder who still owns the purchasing relationship. Recurring revenue in a plant is repeat releases and a contract that assigns, not a website retainer.
Equipment age
Book value is an accounting leftover. Sponsors want remaining useful life, the maintenance log, open liens, and the capex you have been deferring. Customer-owned tooling is not your collateral and it may not transfer. A line that only one technician can keep in tolerance is a person, not a machine. Deferred replacement comes out of the price or out of the multiple. A high multiple on earnings that need a new cell in year one is a lower price with extra steps. Specialized iron a used machine can replace will not be paid for dollar-for-dollar.
The supervisor bench
This is the item that sorts platform from add-on more cleanly than revenue. A platform buyer needs a plant manager, a quality lead, and a shift supervisor who already run Tuesday when you are off the floor. An add-on buyer may bring that bench from the plant they already own, which is why they pay less for yours. If the only person who can release a job, talk to the OEM, and restart the cell is you, you are selling a job plus equipment. Name the bench in an org chart that matches the payroll. A title with no one under it does not count.
A founder-run job shop can still sell. The buyer is often an owner-operator, a strategic who wants the process, or a small add-on that will fold the work into another building. That is a real sale. It is a different sale from a platform. Our manufacturing sale page is the place to start if you are still sorting which of those you have.
Why the Same P&L Gets 6x or 9x
Use one earnings number. Say adjusted EBITDA is $3 million after a market wage for a general manager, not before. The add-on conversation at 6x is $18 million. The platform conversation at 9x is $27 million. The $9 million gap is not a better year. It is who has to go find the next plant manager, the lender, and the next acquisition.
An add-on multiple
An add-on multiple prices you as a piece of a company that already exists. The platform has a GM, a board, a lender, and a map. They want your capacity, a certification, a customer you have and they call on, or a region they are missing. They can pay 6x of your earnings and still be buying the combined company at a lower multiple, because they expect to take cost out: a second front office, a duplicate quality system, sometimes a shift. Those synergies belong to them. You do not get paid for savings you will not keep. The multiple rises when you are the missing process and they will pay to keep you away from another platform. It falls when they can hire the crew and buy the machines without you.
A platform multiple
A platform multiple prices you as the bet. The fund does not yet have this plant, or the one they have is too small to bolt others onto. They underwrite your earnings plus a path: a bench that can absorb an acquisition, reporting they can read on the first Monday, and a customer book that survives a change of control. Nine times is the illustration for that file when the four items above are clean. It is not a promise, and it is not the multiple for a shop the founder still quotes. If the bench is missing, a careful sponsor does not stretch to 9x. They reclassify you as an add-on, or they pass. Asking for a platform price with an add-on file is how a process dies in the second meeting.
Cash is not the multiple. A 9x platform offer with a quarter of the equity rolled is not 9x in proceeds. A 6x add-on that is mostly cash at closing can be the better wire. Read the rollover, the preference, and the job they want you to keep before you rank the headlines. That math is in rollover equity and the second bite. Debt on the company after closing is their structure until it sits in front of the shares you kept.
Below the size where a fund will build a platform, the buyer set changes again. Once a sale is large enough that a sponsor’s model is the conversation — the shift we describe when a sale crosses $20 million — the 6x and 9x illustration is the right argument. Under that, a strategic or an operator may be the real market, and a sponsor’s teaser is a fishing email. Put both kinds of buyers on the same earnings definition before anyone is exclusive. Who runs that process matters, because a listing that only calls local owner-operators will never see the platform bid, and a process that only calls funds will miss the strategic who would have paid cash.
Out-of-State PE and an Established Southeast Plant
Sponsors do not need the plant to sit next to their office. They buy established operations: customers already qualified, a crew that already holds the tolerances, certificates that already exist. A Florida precision shop and a Midwest or Carolina plant get read on the same four items. The flight is a cost. The file is the product.
Out-of-state funds show up in the Southeast for that reason. They are not buying a startup in a growth story. They are buying a plant that already ships. Jacksonville, Lakeland, Tampa, and Melbourne all have light manufacturing on the ground — see the Lakeland and Jacksonville pages for how a local book is actually underwritten — and the same pattern shows up in a Midwest plant town. A Pella shop that lives on one program is concentration whether the buyer’s office is in Florida or Chicago. Geography is the tour. It is not the multiple.
We have already run this kind of file in Florida. A second-generation precision manufacturer, prepared over about fourteen months, drew both strategic buyers and private equity groups that focus on manufacturing. The close was $40 million to a strategic buyer, which is the point of a competitive process: PE in the room is leverage even when a strategic writes the check. The confidential write-up is from preparation to a $40 million exit. Details were changed to protect the company. The lesson that transfers is preparation and a real buyer list, not a claim that every Southeast plant clears a platform multiple.
What out-of-state sponsors worry about is practical. Who meets them if you are the only person who can walk the floor. Whether the largest customer will take a call from a fund they have never heard of. Whether the building, the environmental file, and the leases assign. Whether you will stay long enough for their operating partner to learn the cell. None of that is fixed by being in Florida. It is fixed by the punch list below, and by a confidential process so the OEM does not hear you are for sale from a teaser.
The 12-Month Punch List That Changes the Buyer
The generic 12–36 month sale-prep roadmap still applies: normalized earnings, a data room, a reason you are selling. This list is narrower. It is the work that moves a plant from “add-on, if we bother” to “platform we will bid.” If you finish it and the bench is still you, stop asking for a platform process and sell as an add-on on purpose. That is a better outcome than a failed 9x story.
Months 1–3: make the four items visible. Build a backlog bridge: firm releases, blankets, and pipeline, each with margin and cancel terms. A one-page concentration table for the top ten customers. An equipment register with year, liens, and the capex you already know is coming. An org chart that matches payroll, with the founder’s hours written down. If any of those documents only exist in your head, the buyer type is already decided.
Months 4–6: put a bench on the clock. Name a plant manager or a shift lead who releases work without you for a full month, then another. Maintenance logs move off one technician’s notebook. Quality approvals have a second signature. If you cannot do this, you will be an add-on or a strategic’s tuck-in, and the next six months should make that sale clean rather than pretend otherwise.
Months 7–9: change the concentration story or document why it will not change. Extend a term, add a second program, or show a quote log that is not one OEM. Customer-owned tooling gets a list and a letter. Certifications that expire on a change of control get read now. A sponsor will not discover an ISO or a NADCAP transfer problem after exclusivity and still pay a platform price.
Months 10–12: a monthly package and a buyer decision. Earnings bridge, backlog bridge, and capex, in the same format three months in a row. Then choose the invitation. If the bench ran the quarter, invite platform funds and strategics, and keep add-on buyers in the process so the platform price has to compete. If the bench did not, invite add-on platforms and strategics who want the process, price the file on the earnings they can keep, and do not anchor the ask to 9x. A valuation at the start of this year, and again before you go out, is how you know which invitation is honest. M&A advisory is the outreach. The punch list is what makes the outreach true.
Owners who skip the list and take the first add-on call often leave the platform bid untested. Owners who skip the list and demand a platform price spend a year educating funds that were never going to stretch. Twelve months is enough to change the label. It is not enough to rebuild a plant.
Talk With Bridge Point
If you are going to sell a manufacturing company, the first decision is which buyer the file can actually support. Bridge Point Business Brokers works with owners who want that answer before a teaser goes out: backlog, concentration, equipment, and the bench, then a process that can include both a platform and an add-on without letting either set the price alone. Start with a confidential business valuation, the manufacturing sale page, or contact us. Call (352) 515-0226.
Frequently Asked Questions
What is the difference between a PE platform and an add-on buyer?
A platform is the company a fund will build on: they need your earnings, your bench, and a path to buy more plants. An add-on is a purchase by a company the fund already owns. They want your capacity, a certification, a customer, or a region, and they often already have the manager. The same P&L is priced differently because you are the bet in one case and a piece of someone else's bet in the other.
Why would the same plant get 6x from one buyer and 9x from another?
Those figures are an illustration, not a quote. On the same adjusted EBITDA, an add-on bid around 6x prices you as a tuck-in. A platform bid around 9x prices you as the company the fund will bolt others onto. The gap disappears if the founder is still the only person who can run the shift, if one customer is the book, or if the equipment needs a replacement the price ignored. Cash at closing also depends on any rollover.
What does private equity underwrite in a manufacturing company?
Backlog quality, customer concentration, equipment age, and the supervisor bench. Firm releases with a margin beat a blanket order that can be cancelled. One OEM changes the structure. Book value is not remaining life. A platform needs managers who already run a shift without the founder. An add-on may bring those managers and pay less.
Do out-of-state private equity firms buy Southeast plants?
Yes, when the operation is already established: qualified customers, a crew, and certificates that exist. A Florida plant and a Midwest or Carolina plant are read on the same four items. The state is the tour. It is not the multiple. A prepared Florida precision manufacturer in our files drew both sponsors and strategics and closed with a strategic buyer at $40 million.
What should I do in the next 12 months if I want platform buyers to bid?
Make backlog, concentration, equipment, and the org chart visible in the first quarter. Put a shift lead on the clock without you in the second. Fix or document concentration and any certificate that dies on a change of control in the third. Close the year with three months of the same reporting package, then invite platform funds only if that bench actually ran the quarter.
Can a founder-run job shop still sell to private equity?
Sometimes, as an add-on or not at all. A fund that needs a platform will pass or reclassify you. Owner-operators and strategics who want the process are often the real buyer. Selling into that set on purpose is a better result than anchoring the ask to a platform multiple the file cannot support.
How is a PE manufacturing sale different from a sale to a strategic buyer?
A strategic pays for a process, a qualification, or capacity they will use themselves, often in cash. A sponsor pays for a financial model: platform or add-on, usually with a rollover and a reporting calendar. Run both on the same EBITDA. A strategic who was in the room is one reason a sponsor's number stays honest, which is what happened in the Florida manufacturing process that closed at $40 million.
Ready to Take the Next Step?
Bridge Point Business Brokers helps business owners nationwide plan and execute successful exits. Schedule a confidential, no-obligation consultation today.